Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

» Andere revante producten voor THIM studenten en medewerkers.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Netherlands Heart Journal
Gepubliceerd in:

01-10-2011 | Original Article

A comparison of clinical outcomes of Chinese sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease

Auteurs: M. Yu, Y.-J. Zhou, Z.-J. Wang, D.-M. Shi, Y.-Y. Liu, Y.-X. Zhao, Y.-H. Guo, W.-J. Cheng, Y.-P. Li, H.-Y. Ma

Gepubliceerd in: Netherlands Heart Journal | Uitgave 10/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Background

Chinese sirolimus-eluting stents (SES) have been widely used in recent years. However, the comparison of clinical outcomes between Chinese and foreign SES remains unknown.

Objectives

To compare the outcomes of Chinese SES (Firebird) with foreign SES (Cypher Select) in the treatment of patients undergoing percutaneous coronary intervention (PCI).

Methods

4000 consecutive patients treated with SESs from January 2008 to December 2009 were included in this study. Based on the differences of the stents, the patients were divided into a Chinese SES group (Firebird; n = 2008) and a foreign SES group (Cypher Select; n = 1992). Outcomes were monitored for 1 year. The primary clinical endpoint was major adverse cardiac events (MACE): a composite of death, non-fatal myocardial infarction (MI) and target-vessel revascularisation (TVR).

Results

No differences were observed in the incidence of MACE (17.8% vs. 18.6%, p = 0.514) and TVR rate (9.0% vs. 8.6%, p = 0.632) during 1-year follow-up.

Conclusions

Chinese SES and foreign SES have similar effects on 1-year clinical outcomes and safety.
vorige artikel Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation
volgende artikel Three-dimensional echocardiography for left ventricular quantification: fundamental validation and clinical applications
Literatuur
1.
Bental T, Assali A, Vaknin-Assa H, et al. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv. 2010;76(3):374–80.PubMedCrossRef
2.
Schomig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(14):1373–80.PubMedCrossRef
3.
Beijk MA, Koch KT, Tijssen JG, et al. A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria. Coron Artery Dis. 2010 2010-11-02.
4.
Ferreira E, Araujo DV, Azevedo VM, et al. Analysis of the cost-effectiveness of drug-eluting and bare-metal stents in coronary disease. Arq Bras Cardiol. 2010;94(3):286–92. 306–12.PubMedCrossRef
5.
Cheng JM, Onuma Y, Piazza N, et al. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). Am J Cardiol. 2010;106(10):1376–81.PubMedCrossRef
6.
Hirlekar R, Patel M, Jain S, et al. Drug eluting coronary artery stents. Curr Drug Deliv. 2010 2010-10-26.
7.
Martin DM, Boyle FJ. Drug-eluting stents for coronary artery disease: A review. Med Eng Phys. 2010 2010-11-12.
8.
Park KW, Kang SH, Chung WY, et al. ‘Real world’ comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. Circ J. 2010;74(6):1111–20.PubMedCrossRef
9.
Stone GW, Parise H, Witzenbichler B, et al. Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2010;56(19):1597–604.PubMedCrossRef
10.
Spaulding C, Rosencher J, Varenne O. Use of drug eluting stents in ST segment elevation myocardial infarction. Heart. 2010;96(13):1073–7.PubMedCrossRef
11.
Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.PubMedCrossRef
12.
Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38(7):2114–30.PubMedCrossRef
13.
Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–9.PubMedCrossRef
14.
Liu HB, Xu B, Gao RL, et al. Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry. Chinese Med J-Peking. 2006 2006-06-16(7):609–11.
15.
Xu B. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird stent. Chin Med J. 2008;121(6):492–7.PubMed
16.
Chen F, Gao YC, He JQ, et al. A comparison of clinical outcomes after domestic sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease. Chin J Cardiol. 2006;34(11):994–9.
Metagegevens
Titel
A comparison of clinical outcomes of Chinese sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease
Auteurs
M. Yu
Y.-J. Zhou
Z.-J. Wang
D.-M. Shi
Y.-Y. Liu
Y.-X. Zhao
Y.-H. Guo
W.-J. Cheng
Y.-P. Li
H.-Y. Ma
Publicatiedatum
01-10-2011
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 10/2011
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-011-0177-2

Andere artikelen Uitgave 10/2011

Three-dimensional echocardiography for left ventricular quantification: fundamental validation and clinical applications

  • Open Access
  • Review Article

Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres

  • Open Access
  • Original Article

Treatment of atrial fibrillation in the elderly: time for a change?

  • Editorial

Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation

  • Original Article

Per-operative stent placement in the right pulmonary artery; a hybrid technique for the management of pulmonary artery branch stenosis at the time of pulmonary valve replacement in adult Fallot patients

  • Open Access
  • Special Article

Percutaneous treatment of native aortic coarctation in adults

  • Open Access
  • Case Report